G protein-dependent activation of mast cell by peptides and basic secretagogues

Peptides

Volumn 23, Issue 8, 2002, Pages 1507-1515

  Ferry, Xavier ^a   Brehin, Stephan ^a   Kamel, Rehab ^a   Landry, Yves ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Basic secretagogues; Cell penetrating peptides; Compound 48 80; Defensins; G proteins; Mast cells; Mastoparan; Neuropeptides; Venom peptides

Indexed keywords

AGMATINE; ANAPHYLATOXIN; ARACHIDONIC ACID; BENZALKONIUM CHLORIDE; BRADYKININ; CALCIUM; CANNABINOID DERIVATIVE; CARRIER PROTEIN; CATHELICIDIN; CATION; COMPOUND 48-80; DEFENSIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MAST CELL DEGRANULATING PEPTIDE; MASTOPARAN; MEMBRANE RECEPTOR; MORPHINE DERIVATIVE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [18-36]; NEUROTENSIN; PERTUSSIS TOXIN; POLYAMINE DERIVATIVE; POLYMYXIN B; SECRETORY PROTEIN; SOMATOSTATIN; SUBSTANCE P; SUBSTANCE P [4-11][4 DEXTRO PROLINE 7,9,10 DEXTRO TRYPTOPHAN]; SUBSTANCE P ANTAGONIST; SUBSTANCE P DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE;

BETA CHAIN; CELL ACTIVATION; CELL MEMBRANE TRANSPORT; CELL SURFACE; EXOCYTOSIS; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; SEROSA; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; GTP-BINDING PROTEINS; HUMANS; MAST CELLS; NEUROPEPTIDE Y; NEUROTENSIN; PEPTIDES; PROTEIN TRANSPORT; RATS; SUBSTANCE P;

EID: 0036701254     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00090-6     Document Type: Review

References (105)

1. Amellal M., Landry Y. Lanthanides are transported by ionophore A23187 and mimic calcium in the histamine secretion process. Br. J. Pharmacol. 80:1983;365-370.
2. Argiolas A., Pisano J.J. Isolation and characterization of two new peptides, mastoparan C and crabrolin, from the venom of the European hornet Vespa crabro. J. Biol. Chem. 259:1984;10106-10111.
3. i3. Science. 262:1993;1569-1572.
4. Aridor M., Sagi-Eisenberg R. Neomycin is a potent secretagogue of mast cells that directly activates a GTP-binding protein involved in exocytosis. J. Cell Biol. 111:1990;2885-2891.
5. Aridor M., Traub L.M., Sagi-Eisenberg R. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J. Cell Biol. 111:1990;909-917.
6. Bals R., Wang X., Zasloff M., Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U.S.A. 95:1998;9541-9546.
7. Barrocas A.M., Cochrane D.E., Carraway R.E., Feldberg R.S. Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C. Immunopharmacology. 41:1999;131-137.
8. Becker S., Hadding U., Schorlemmer H.U., Bitter-Suermann D. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets. Scand. J. Immunol. 8:1978;551-555.
9. Befus A.D., Mowat C., Gilchrist M., Hu J., Solomon S., Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J. Immunol. 163:1999;947-953.
10. Blomqvist A.G., Herzog H. Y-receptor subtypes - how many more? Trends Neurosci. 20:1997;294-298.
11. 2+-sensing receptor from bovine parathyroid. Nature. 366:1993;575-580.
12. Bueb J.L., Da Silva A., Mousli M., Landry Y. Natural polyamines stimulate G-proteins. Biochem. J. 282:1992;545-550.
13. Bueb J.L., Lambert D.M., Tschirhart E.J. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. Biochim. Biophys. Acta. 1538:2001;252-259.
14. i-like proteins, a receptor-independent effect of kinins in mast cells. Mol. Pharmacol. 38:1990;816-822.
15. Bueb J.L., Mousli M., Landry Y., Regoli D. Structure-activity studies of bradykinin analogues on rat mast cell histamine release. Peptides. 14:1993;685-689.
16. Buku A. Mast cell degranulating (MCD) peptide: a prototypic peptide in allergy and inflammation. Peptides. 20:1999;415-420.
17. Carraway R., Cochrane D.E., Lansman J.B., Leeman S.E., Paterson B.M., Welch H.J. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol. 323:1982;403-414.
18. Chahdi A., Mousli M., Landry Y. Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface. Eur. J. Pharmacol. 341:1998;329-335.
19. Chaloin L., Vidal P., Heitz A., Van Mau N., Mery J., Divita G.et al. Conformations of primary amphipathic carrier peptides in membrane mimicking environments. Biochemistry. 36:1997;11179-11187.
20. Cross L.J., Beck-Sickinger A.G., Bienert M., Gaida W., Jung G., Krause E.et al. Structure-activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br. J. Pharmacol. 117:1996;325-332.
21. Cochrane D.E. Peptide regulation of mast cell function. Prog. Med. Chem. 27:1990;143-188.
22. Cross L.J., Ennis M., Krause E., Dathe M., Lorenz D., Krause G.et al. Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation. Eur. J. Pharmacol. 291:1995;291-300.
23. i proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine. Br. J. Pharmacol. 127:1999;1021-1029.
24. Daeffler L., Nadra K., Eichwald V., Ohresser S., Landry Y. Effect of NMDA receptor ligands on mast cell histamine release, a reappraisal. Naunyn Schmiedebergs Arch. Pharmacol. 359:1999;512-518.
25. Devillier P., Drapeau G., Renoux M., Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. Eur. J. Pharmacol. 168:1989;53-60.
26. Devillier P., Renoux M., Drapeau G., Regoli D. Histamine release from rat peritoneal mast cells by kinin antagonists. Eur. J. Pharmacol. 149:1988;137-140.
27. Devillier P., Renoux M., Giroud J.P., Regoli D. Peptides and histamine release from rat peritoneal mast cells. Eur. J. Pharmacol. 117:1985;89-96.
28. El-Lati S.G., Dahinden C.A., Church M.K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest Dermatol. 102:1994;803-806.
29. Emadi-Khiav B., Mousli M., Bronner C., Landry Y. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. Eur. J. Pharmacol. 272:1995;97-102.
30. Ember J.A., Hugli T.E. Complement factors and their receptors. Immunopharmacology. 38:1997;3-15.
31. Feldberg R.S., Cochrane D.E., Carraway R.E., Brown E., Sawyer R., Hartunian M.et al. Evidence for a neurotensin receptor in rat serosal mast cells. Inflamm. Res. 47:1998;245-250.
32. i3 proteins by basic secretagogues induces exocytosis through phospholipase Cβ and arachidonate release through phospholipase Cγ in mast cells. J. Immunol. 167:2001;4805-4813.
33. Ferry X., Landry Y. Agmatine: a mastoparan-like activity related to heterotrimeric G proteins direct activation. Eur. J. Pharmacol. 435:2002;19-26.
34. Fewtrell C.M., Foreman J.C., Jordan C.C., Oehme P., Renner H., Stewart J.M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol. 330:1982;393-411.
35. Fischer T., Bronner C., Landry Y., Mousli M. The mechanism of inhibition of alkylamines on the mast cell peptidergic pathway. Biochim. Biophys. Acta. 1176:1993;305-312.
36. Foreman J.C., Mongar J.L., Gomperts B.D. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature. 245:1973;249-251.
37. Fujimoto I., Oiki S., Kondo T., Katada T., Kato H., Taguchi T.et al. GTP-binding protein activation underlies LTP induction by mast cell degranulating peptide. Neurosci. Res. 25:1996;229-237.
38. Fujimoto I., Ikenaka K., Kondo T., Aimoto S., Kuno M., Mikoshiba K. Mast cell degranulating (MCD) peptide and its optical isomer activate GTP binding protein in rat mast cells. FEBS Lett. 287:1991;15-18.
39. +/peptide transporter PEPT2 mediated transport system. Neurosci. Lett. 271:1999;117-120.
40. Fukuoka Y., Hugli T.E. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. J. Immunol. 145:1990;1851-1858.
41. Gies J.P., Landry Y., Mousli M. Receptor-independent activation of mast cells by bradykinin and related peptides. Trends Neurosci. 16:1993;498-499.
42. Griesbacher T., Rainer I. 5-Hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors. Immunopharmacology. 43:1999;195-201.
43. Grundemar L., Krstenansky J.L., Hakanson R. Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins? Eur. J. Pharmacol. 258:1994;163-166.
44. o by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J. Biol. Chem. 265:1990;14176-14186.
45. Higashijima T., Uzu S., Nakajima T., Ross E.M. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem. 263:1988;6491-6494.
46. Hino R.H., Lau C.K., Read G.W. The site of action of the histamine releaser compound 45/80 in causing mast cell degranulation. J. Pharmacol. Exp. Ther. 200:1977;658-663.
47. Hirai Y., Yasuhara T., Yoshida H., Nakajima T., Fujino M., Kitada C. A new mast cell degranulating peptide mastoparan in the venom of Vespula lewisii. Chem. Pharm. Bull (Tokyo). 27:1979;1942-1944.
48. Hussain I., Zanic-Grubisic T., Kudo Y., Boyd C.A. Functional and molecular characterization of a peptide transporter in the rat PC12 neuroendocrine cell line. FEBS Lett. 508:2001;350-354.
49. Igarashi K., Kashiwagi K. Polyamine transport in bacteria and yeast. Biochem. J. 344:1999;633-642.
50. Johnson A.R., Erdos E.G. Release of histamine from mast cells by vasoactive peptides. Proc. Soc. Exp. Biol. Med. 142:1973;1252-1256.
51. Johnson A.R., Moran N.C. Selective release of histamine from rat mast cells by compound 48-80 and antigen. Am. J. Physiol. 216:1969;453-459.
52. Joliot A.H., Triller A., Volovitch M., Pernelle C., Prochiantz A. Alpha-2,8-polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide. New Biol. 11:1991;1121-1134.
53. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17:1999;931-972.
54. Klinker J.F., Hageluken A., Grunbaum L., Seifert R. Direct and indirect receptor-independent G-protein activation by cationic-amphiphilic substances. Studies with mast cells, HL-60 human leukemic cells and purified G-proteins. Exp. Dermatol. 4:1995;231-239.
55. Klinker J.F., Seifert R. Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity. Inflamm. Res. 46:1997;46-50.
56. Lagunoff D., Martin T.W., Read G. Agents that release histamine from mast cells. Annu. Rev. Pharmacol. Toxicol. 23:1983;331-351.
57. Lau A.H., Chow S.S., Ng Y.S. Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P. Eur. J. Pharmacol. 414:2001;295-303.
58. Lazarus L.H., Perrin L.H., Brown M.R. Mast cell binding of neurotensin. Part I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites. J. Biol. Chem. 252:1977;7174-7179.
59. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 263:1994;966-969.
60. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21:2000;99-103.
61. Lorentz D., Wiesner B., Zipper J., Winkler A., Krause E., Beyermann M.et al. Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J. Gen. Physiol. 112:1998;577-591.
62. Mazurek N., Pecht I., Teichberg V.I., Blumberg S. The role of the N-terminal tetrapeptide in the histamine releasing action of substance P. Neuropharmacology. 120:1981;1025-1027.
63. McIntire F.C. Histamine release in rabbit blood by simple molecules; inhibition and reaction rate studies. Am. J. Physiol. 167:1951;233-241.
64. Meredith D., Boyd C.A. Structure and function of eukaryotic peptide transporters. Cell Mol. Life Sci. 57:2000;754-778.
65. Miller L.A., Cochrane D.E., Carraway R.E., Feldberg R.S. Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor. Br. J. Pharmacol. 114:1995;1466-1470.
66. Morrison D.C., Roser J.F., Cochrane C.G., Henson P.M. Two distinct mechanisms for the initiation of mast cell degranulation. Int. Arch Allergy Appl. Immunol. 49:1975;172-178.
67. Morrison D.C., Roser J.F., Henson P.M., Cochrane C.G. Activation of rat mast cells by low molecular weight stimuli. J. Immunol. 112:1974;573-582.
68. Mousli M., Hugli T.E., Landry Y., Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. Immunol. 148:1992;2456-2461.
69. Mousli M., Bronner C., Bockaert J., Rouot B., Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol. Lett. 25:1990;355-357.
70. Mousli M., Bronner C., Bueb J.L., Landry Y. Evidence for the interaction of mast cell-degranulating peptide with pertussis toxin-sensitive G proteins in mast cells. Eur. J. Pharmacol. 207:1991;249-255.
71. Mousli M., Bronner C., Bueb J.L., Tschirhart E., Gies J.P., Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J. Pharmacol. Exp. Ther. 250:1989;329-335.
72. Mousli M., Bueb J.L., Bronner C., Rouot B., Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci. 11:1990;358-362.
73. Mousli M., Trifilieff A., Pelton J.T., Gies J.P., Landry Y. Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur. J. Pharmacol. 289:1995;125-133.
74. Mukherjee S., Ghosh R.N., Maxfield F.R. Endocytosis. Physiol. Rev. 77:1997;759-803.
75. Nadler M.J., Matthews S.A., Turner H., Kinet J.P. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 76:2000;325-355.
76. 2+ mobilizing receptor-mediated biosignaling system. J. Biol. Chem. 260:1985;3584-3593.
77. 2 production from mast cells. Eur. J. Immunol. 31:2001;1066-1075.
78. Oehlke J., Krause E., Wiesner B., Beyermann M., Bienert M. Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett. 415:1997;196-199.
79. Paton W.D.M. Compound 48/80: a potent histamine liberator. Br. J. Pharmacol. 6:1951;499-508.
80. Paton W.D.M. Histamine release by compounds of simple chemical structure. Pharmacol. Rev. 9:1957;269-321.
81. Piotrowski W., Devoy M.A., Jordan C.C., Foreman J.C. The substance P receptor on rat mast cells and in human skin. Agents Actions. 14:1984;420-424.
82. Piotrowski W., Foreman J.C. On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol. 331:1985;364-368.
83. Polley M.J., Nachman R.L. Human platelet activation by C3a and C3a des-arg. J. Exp. Med. 158:1983;603-615.
84. Regoli D., Nguyen K., Calo G. Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology. Ann. N. Y. Acad. Sci. 812:1997;144-146.
85. Regoli D., Nsa Allogho S., Rizzi A., Gobeil F.J. Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 348:1998;1-10.
86. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci. 21:2000;187-193.
87. Reissmann S., Pineda F., Vietinghoff G., Werner H., Gera L., Stewart J.M.et al. Structure-activity relationships for bradykinin antagonists on the inhibition of cytokine release and the release of histamine. Peptides. 21:2000;527-533.
88. Repke H., Bienert M. Mast cell activation, a receptor-independent mode of substance P action? FEBS Lett. 221:1987;236-240.
89. Rothschild A.M. Histamine release by basic compounds. Handbook Exp Pharmacol. 28:1966;386-430.
90. Saier M.H. Jr. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev. 64:2000;354-411.
91. Satriano J., Isome M., Casero R.A. Jr., Thomson S.C., Blantz R.C. Polyamine transport system mediates agmatine transport in mammalian cells. Am. J. Physiol. Cell Physiol. 281:2001;C329-C334.
92. Schwarze S.R., Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21:2000;45-48.
93. Shen G.H., Grundemar L., Zukowska-Grojec Z., Hakanson R., Wahlestedt C. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents. Eur. J. Pharmacol. 204:1991;249-256.
94. Shibata H., Mio M., Tasaka K. Analysis of the mechanism of histamine release induced by substance P. Biochim. Biophys. Acta. 846:1985;1-7.
95. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
96. Tomita U., Takahashi K., Ikenaka K., Kondo T., Fujimoto I., Aimoto S.et al. Direct activation of GTP-binding proteins by venom peptides that contain cationic clusters within their alpha-helical structures. Biochem. Biophys. Res. Commun. 178:1991;400-406.
97. Vietinghoff G., Paegelow I., Reissmann S. Induction of histamine release from rat mast cells by bradykinin analogues. Peptides. 17:1996;1467-1470.
98. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20:1999;302-309.
99. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 33:1993;309-352.
100. Wedemeyer J., Galli S.J. Mast cells and basophils in acquired immunity. Br. Med. Bull. 56:2000;936-955.
101. Wuepper K.D., Bokisch V.A., Muller-Eberhard H.J., Stoughton R.B. Cutaneous responses to human C3 anaphylatoxin in man. Clin. Exp. Immunol. 11:1972;13-20.
102. Yamashita T., Saito K. Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect. Immun. 57:1989;2405-2409.
103. Yang D., Chertov O., Oppenheim J.J. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc Biol. 69:2001;691-697.
104. Zhao Q.E., Mihara T., Sugimoto Y., Kamei C. Mechanism of bradykinin-induced histamine release from rat peritoneal mast cells. Biol. Pharm. Bull. 19:1996;237-240.
105. Zorko M., Pooga M., Saar K., Rezaei K., Langel U. Differential regulation of GTPase activity by mastoparan and galparan. Arch. Biochem. Biophys. 349:1998;321-328.